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In Brief
The diversity of synaptic adhesion
molecules, and neurexins in particular,
may provide a molecular substrate for the
formation of neural circuits. Using single-
cell qPCR, Fuccillo et al. demonstrate that
individual neurons exhibit unique and
reproducible cell-type-specific neurexin
mRNA repertoires.
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Neurexins are considered central organizers of syn-
apse architecture that are implicated in neuropsychi-
atric disorders. Expression of neurexins in hundreds
of alternatively spliced isoforms suggested that indi-
vidual neurons might exhibit a cell-type-specific neu-
rexinexpressionpattern (aneurexincode). To test this
hypothesis,wequantified thesingle-cell levels of neu-
rexin isoforms andother trans-synaptic cell-adhesion
molecules by microfluidics-based RT-PCR. We show
that the neurexin repertoire displays pronounced
cell-type specificity that is remarkably consistent
within each type of neuron. Furthermore, we uncov-
ered region-specific regulation of neurexin transcrip-
tion and splice-site usage. Finally, we demonstrate
that the transcriptional profiles of neurexins can be
altered in an experience-dependent fashion by expo-
sure to a drug of abuse. Our data provide evidence
of cell-type-specific expression patterns of multiple
neurexins at the single-cell level and suggest that
expression of synaptic cell-adhesionmolecules over-
laps with other key features of cellular identity and
diversity.
INTRODUCTION
Normal brain function relies on the precise development of
neuronal circuits—specific cellular ensembles that exhibit stereo-
typed patterns of connectivity and synaptic functionality (Klaus-
berger andSomogyi, 2008). This organization requires exquisitely
orchestrated developmental programs linking neuronal cell-type
specification to the targeting and formation of synapses with
unique functional characteristics (Duan et al., 2014). The neurexin
family of synaptic adhesion molecules, which are extensively
linked to neuropsychiatric disease, has been proposed to orga-326 Neuron 87, 326–340, July 15, 2015 ª2015 Elsevier Inc.nize synaptic function throughout the nervous system (Missler
et al., 2003; Su¨dhof, 2008). The large genomic footprint of the
three neurexin molecules exhibits astounding complexity, in-
cluding alternative promoter usage, extensive splice-site regula-
tion, and large intronic segments (Tabuchi and Su¨dhof, 2002).
The extensive transcriptional diversity generated from these
genesmakes it possible that neurexin proteins serve asmolecular
backbonessupportingmultiple trans-synaptic interactions in indi-
vidual synapses, which have unique properties throughout the
brain. A central implication of this hypothesis is that neurexin
mRNA expression should be tightly regulated and unique to
each cell type in the circuit—a premise that we directly test here
by using single-cell analysis of neurexin transcriptional and
splice-site isoforms as well as those of other families of synaptic
cell-adhesion molecule.
Neurexin protein diversity is achieved through transcriptional
and post-transcriptional regulation (Ushkaryov et al., 1992; Ull-
rich et al., 1995). All neurexin genes (Nrxn1-Nrxn3 in mice,
NRXN1-NRXN3 in humans) use two promoters that generate
long (a) and short (b) transcripts (Tabuchi and Su¨dhof, 2002;
Ushkaryov et al., 1992; Ushkaryov and Su¨dhof, 1993). In addi-
tion, six canonical sites of alternative splicing in a-neurexins
and two such sites in b-neurexins, if utilized independently,
potentially generate thousands of distinct isoforms (Ullrich
et al., 1995), a hypothesis that was confirmed by recent studies
using long, single-molecule sequencing (Treutlein et al., 2014;
Schreiner et al., 2014). Crystal structures of Nrxn1a and Nrxn1b
have revealed that alignment of their domains creates multiple
binding pockets capable of interacting with several proteins,
thereby mediating neurexin’s function as a synaptic ‘‘hub’’ mole-
cule (Arac¸ et al., 2007; Chen et al., 2010, 2011; Comoletti et al.,
2010). The alternatively spliced sequences often line these bind-
ing pockets, thus modulating neurexin-binding activities. These
data suggest that, through regulation of neurexin mRNA expres-
sion and alternative splicing, neurons modulate binding to a se-
ries of trans-synaptic partners to sculpt synaptic connectivity
and function (Aoto et al., 2013; Boucard et al., 2005; Siddiqui
et al., 2010; Soler-Llavina et al., 2011, 2013; Treutlein et al.,
2014). To date, the diversity of neurexin mRNA expression has
been explored by in situ hybridization as well as by global anal-
ysis of mRNA isolated from dissected tissue, using both direct
sequencing and qRT-PCR (Ullrich et al., 1995; Aoto et al.,
2013; Treutlein et al., 2014; Schreiner et al., 2014). However,
while current single-molecule, deep-sequencing approaches
have identified predominant neurexin mRNA species, they
lacked cellular resolution and do not reveal the expression of
specific neurexin isoforms in particular types of neurons.
The role for neurexins in regulating synaptic diversity of micro-
circuits likely takes place on a cell-by-cell basis, therefore re-
quiring techniques that assess mRNA expression of individual
neurons to fully understand the role of neurexins in circuit for-
mation and function. At single-cell resolution, the unanswered
questions are numerous: for instance, is neurexin diversity man-
ifest at the single-cell level, and, if so, what are the relative con-
tributions of transcriptional regulation and alternative splicing?
Are neurexin transcription profiles common within specific cir-
cuits, or does each functional unit have unique transcript
patterns? How is neurexin expression related to that of other
pre- and postsynaptic adhesion modules? Finally, are cellular
neurexin transcription profiles static, or can they be remodeled
by behavioral experience? The present study leverages current
advances in single-cell transcription profiling with genetic tools
for circuit dissection to examine the diversity of synaptic cell-
adhesion molecule expression and to assess how such diversity
relates to specific cell types and patterns of connectivity. We find
that neurexin transcriptional repertoires are cell type specific but
are not related to particular synaptic connectivity. Furthermore,
neurexins display a brain-region-specific coordination of alter-
native splicing at the single-cell level. Finally, we demonstrate
that neurexin expression profiles are plastic, in that they can
be altered by exposure to drugs of abuse.
RESULTS
Single-Cell Neurexin Expression Profiles Are Distinct
from Those Observed in Tissue Samples
Our characterization of neurexin expression profiles of select
neuronal circuits relied upon two methodologies: first, BAC
(bacterial artificial chromosome) transgenic mice or rabies-virus
(RV)-mediated retrograde tracing to select neurons that are con-
stituents of a particular circuit by cell type or patterns of connec-
tivity; second, the design and characterization of a library of
qPCR assays that could specifically detect splice isoforms of
neurexin transcripts. Using a Fluidigm microfluidics platform,
we tested over 150 probes on cytosol of single neurons aspi-
rated through a patch pipette from acute slices (Figure 1A).
Probe-based qPCR assays were constructed to investigate a
substantial fraction of the numerous neurexin splice sites (Fig-
ure 1B). Splice-site-specific primers were designed to detect
omission of an intervening exon, designated as splice site out
(ss-OUT), or inclusion of an intervening exon, designated as
splice site in (ss-IN) (Figure 1C). The amplification efficiency (Fig-
ure 1D) and specificity (Figure 1E) of all probes were tested on
tissue mRNA from multiple brain regions as well as plasmids
containing specific splice isoforms. Using this strategy, we
were able to generate a primer library encompassing themajority
of potential neurexin mRNA variants, including specific spliceisoforms and the two major transcriptional species for each neu-
rexin gene (see Table S1 for primer info).
To date, analysis of neurexin expression diversity has been
performed exclusively on mRNA extracted from neuronal tissue
and cultured neurons, potentially masking cell-type- and cir-
cuit-specific differences (Ullrich et al., 1995; Aoto et al., 2013;
Treutlein et al., 2014; Schreiner et al., 2014;). To reliably uncover
patterns of neurexinmRNA expression at the single-neuron level,
it is essential to minimize the experimental variability introduced
by inconsistencies in qPCR detection or cytosolic input material.
Replication experiments on a subset of single-cell cDNAsamples
demonstrated a nearly linear fit between qPCR runs, suggesting
that microfluidics-based transcript detection is reliable from trial
to trial (Figure 1F). Furthermore, initial cytosolic mRNA input was
largely consistent across single cells, as judged by average cycle
threshold (Ct) values for three housekeeping probes used in sub-
sequent normalization steps (Figure 1G). To test whether our
approach can differentiate neurexin expression at the single-
cell level from that of the surrounding tissue, we compared the
transcriptional profiles of the a- and b-variants of Nrxn1, Nrxn2,
and Nrxn3 from micro-dissected hippocampal CA1 tissue with
single cells from the CA1 pyramidal layer or isolated putative
cholecystokinin-positive (CCK+) interneurons within the stratum
radiatum (Figure 1H). Single-cell mRNA extraction by somatic
patch-pipette aspiration consistently reduced the level of de-
tected glial transcripts, which are expectedly present in tissue
samples (Figure S1). Consistent with the preponderance of pyra-
midal cells in the CA1 field, tissue expression values of neurexins
were similar to averaged single CA1 pyramidal cell expression
levels (Figure 1H). In contrast, tissue expression levels clearly
diverged from those of averaged putative CCK cells, a subclass
of interneuron far less numerous than hippocampal pyramidal
cells (Figure 1H). Perhaps due to its GC-rich sequence content,
wewere unable to reliably detectNrxn2 isoformsboth from tissue
samples and from single cells, prompting us to omit Nrxn2 from
the remaining analyses (Figure 1H). Overall, these data suggest
that single-neuron neurexin transcriptional analysis is feasible
and robust and can provide novel insights into the cellular regula-
tion of synaptic cell-adhesion networks.
Neurexin Expression Repertoires Exhibit Pronounced
Cell-Type Specificity across Multiple Microcircuits
Our initial data suggest that CCK interneurons display neurexin
transcriptional profiles that are distinct from surrounding CA1
pyramidal cells. To determine whether this transcriptional diver-
sity is shared by other local circuit GABAergic interneurons in
the stratum radiatum, we targeted another well-defined cell
population for mRNA profiling: parvalbumin-positive (PV+) inter-
neurons, which share postsynaptic targets with CCK cells but
display highly divergent synaptic properties (Freund and Katona,
2007). PV-Cre mice were crossed with AI9 reporter mice to label
the PV+ subclass, and the cytosol of fluorescent cells in close
proximity to the CA1 hippocampal pyramidal cell layer was aspi-
rated from acute hippocampal slices (Figure 2A) (Hippenmeyer
et al., 2007; Madisen et al., 2010). We identified CCK+ cells
based on their soma location—similar to that of PV+ cells—their
larger soma sizes, and absence of red fluorescence. While none
of these characteristics are alone sufficient to identify these cellNeuron 87, 326–340, July 15, 2015 ª2015 Elsevier Inc. 327
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Figure 1. Single-Cell Neurexin Transcriptional Profiles Are Distinct from Those Observed in Tissue Samples
(A) Left: image of 403 fluorescent field showing pipette extraction (solid outline) of GFP-positive cell (dotted outline) fromadult striatum. Right: cellular contents and
nucleus (arrow) within the extraction pipette. Bottom: General workflow from single-cell extraction to target-specific amplification of reverse-transcribed cDNA.
(B) Schematic depicting the genomic architecture of Nrxn1–3.
(C) An example strategy for the design of Nrxn2 ss4-specific primers is shown, which uses common forward primer and internal probe with unique reverse primer
to differentiate inclusion or skipping of exon 21.
(D) Primer efficiency determination through plotting of Ct versus mRNA concentration in serial dilution.
(E) Heatmap representation of Ct for plasmid DNA with known splice-site content.
(F) Measurement of trial-to-trial qPCR variability (experiment 1 versus experiment 2) for all probes across single-cell cDNAs (n = 24) demonstrates a near-linear fit
(red line).
(G) Assessment of input variability for CA1 pyramidal cells and CCK+ interneurons by plotting of Ct for three normalization probes across all collected single cells
(red indicates a three-probe average).
(H) Top: schematic depicting mRNA isolation from hippocampal CA1 field for transcriptional analysis of hippocampal tissue (n = 6) and individual CA1 pyramidal
cells (n = 7) or stratum radiatum CCK interneurons (n = 22). Bottom: averaged normalized expression for the long and short neurexin transcriptional isoforms for
hippocampal tissue and single-cell populations.
Data are means ± SEM. Asterisk indicates significant difference between groups (ANOVA), with Tukey’s multiple comparison post hoc test.types, our single-cell results demonstrated unique expression of
markers previously associated with PV+ and CCK+ cells in this
region (Figure 2B) (Fo¨ldy et al., 2007; Freund, 2003). Despite
having common pyramidal neuron targets, the neurexin tran-328 Neuron 87, 326–340, July 15, 2015 ª2015 Elsevier Inc.scriptional profiles of PV+ and CCK+ interneurons were highly
distinct, with both Nrxn1a and Nrxn3a/b more abundantly ex-
pressed in CCK+ interneurons than in PV+ interneurons (Figures
2C and 2D).
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Figure 2. Hippocampal Interneurons Exhibit
Cell-Type-Specific Neurexin Expression
Patterns
(A) Illustration of the genetic cross used to label
hippocampal interneurons for pipette extraction.
(B) Left: heatmap representation of normalized
expression of PV+ and CCK+ interneurons for
genes known to mark these subtypes. Right:
averaged single-cell normalized expression for
PV+ (n = 21) and CCK+ (n = 24).
(C and D) Left: Nrxn a/b isoform expression,
normalized to the average level in PV+ cells
(hatched PV bars designate expression value
<1%). Right: splice-site graph showing averaged
single-cell splice isoform expression values for ss-
IN (upward bars) and ss-OUT (downward bars).
(E and F) Averaged single-cell normalized expres-
sion values for neurexin ligands (E, dotted line
separates putative postsynaptic and secreted
protein products) and the Ptp/Slitrk family (F,
dotted line separates receptors from putative
postsynaptic ligands).
(G–J) Pearson coefficient correlation plots
demonstrating the similarity of individual neurons
to the two cell classes being compared for neu-
rexin (G), neurexin ligands (H), the Ptp/Slitrk family
(I), and general neuronal transcripts (J). Cells are
color coded according to their known genetic
identity. The dashed unity line represents cells that
are equally similar to both cell types. Kolmogorov-
Smirnov (KS) values are given for comparison of
single-cell groups.
Data are means ± SEM. Asterisk indicates signifi-
cant difference between groups (Mann-Whitney U
test).Beyond the cell-type-specific regulation of neurexin expres-
sion, further analysis revealed several instances of inverse
splicing patterns between the two cell types—particularly for
the third splice site (ss3) of Nrxn1 and Nrxn3 (Figures 2C and
2D, right panels). To explore how other synaptic adhesion
molecules were regulated compared with neurexin mRNAs, we
analyzed the single-cell expression of known neurexin ligands,
of the protein tyrosine phosphatase receptors, and of Slitrk
family proteins, all of which are proposed to participate in synap-
tic organizing complexes (Figures 2E and 2F) (Boucard et al.,
2014; de Wit et al., 2009; Linhoff et al., 2009; Takahashi and
Craig, 2013; Uemura et al., 2010; Yim et al., 2013). Similar to neu-
rexin expression profiles, these synaptic adhesion moleculesNeuron 87, 326–were differentially regulated between
interneuron populations, as evidenced
by differences in expression of Nlgn3,
Cerebellins, Ptprs, and Slitrks.
To assess whether the expression
profiles of neurexins were predictive of
specific circuit constituents, we used
Pearson coefficient measurements of
neurexin expression covariance between
all single cells. Applying this metric to our
datasets clearly demonstrated that neu-
rexin expression profiles could reliablyseparate interneuron populations (Figure 2G). To assess whether
this was a unique property of neurexin molecules, we again
applied correlation analysis to the same single-cell data, but
instead using probe sets representing neurexin ligands, the
Ptpr and Slitrk families, or more general neuronal transcripts
(Figures 2H–2J; see Figure S4A for probe definitions). Probe
sets for each class could sort single cells into two distinct popu-
lations (Figures 2H–2J), highlighting the extreme transcriptional
diversity between interneuron populations with distinct proper-
ties (Tricoire et al., 2011).
Next, we tested whether cell-type-specific regulation of syn-
aptic cell-adhesion molecules was a general principle. To do
so, we sought another brain structure with similar overall340, July 15, 2015 ª2015 Elsevier Inc. 329
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Figure 3. NAc MSNs Exhibit Cell-Type-Spe-
cific Neurexin Expression Patterns
(A) Illustration of picking strategy to isolate D1R+
and D2R+ MSN subtypes
(B) Left: heatmap representation of normalized
expression of D1R+ and D2R+ MSNs for genes
known to mark these subtypes. Right: averaged
single-cell normalized expression for D1R+ (n =
20) and D2R+ (n = 13).
(C and D) Left: Nrxna/b isoform expression,
normalized to the average level in D1R+ cells
(hatched D1+ MSN bars designate expression
value <1%). Right: splice-site graph showing
averaged single-cell splice isoform expression
values for ss-IN (upward bars) and ss-OUT
(downward bars).
(E and F) Averaged single-cell normalized
expression values for neurexin ligands (E) and the
Ptp/Slitrk family (F).
(G–J) Pearson coefficient correlation plots
demonstrating the similarity of individual neurons
to the two cell classes being compared for neu-
rexins (G), neurexin ligands (H), the Ptp/Slitrk
family (I), and general neuronal transcripts (J).
Cells are color coded according to D1R+ and
D2R+ identity. KS values are given for comparison
of single-cell groups.
Data are means ± SEM. Asterisk indicates signif-
icant difference between groups (Mann-Whitney U
test).neurexin expression levels. Whole-tissue analysis compared
prefrontal cortex (PFC), primary motor cortex (M1), ventral stria-
tum (also known as the nucleus accumbens [NAc]), thalamus,
and cerebellum to hippocampus across our entire synaptic
cell-adhesion probe set (Figure S2). Then, we chose to further
explore the NAc, as it displayed overall neurexin levels most
similar to those in the hippocampus and comprises two major
neuron subclasses whose mRNA expression profiles have
been extensively characterized by fluorescence-activated cell
sorting (FACS) analysis and BAC-trap methodologies (Heiman
et al., 2008; Lobo, 2009). Specifically, the major principal neu-330 Neuron 87, 326–340, July 15, 2015 ª2015 Elsevier Inc.rons of the NAc are D1-receptor-positive
(D1R+) medium spiny neurons (MSNs)
that send their axons to the ventral
tegmental area and D2-receptor-positive
(D2R+) MSNs that project to the ventral
pallidum (Grueter et al., 2012).
To investigate the neurexin profile of
individual MSNs, we extracted cells
from D1-Tomato BAC transgenic mice,
which express tdTomato exclusively in
D1R+ MSNs (Figure 3A) (Shuen et al.,
2008). Fluorescently labeled cells were
positive for D1R transcripts, while non-
labeled cells strongly expressed D2R
mRNAs (Figure 3B). Our single-cell data
confirmed previous tissue-based expres-
sion analyses and assured us that visually
guided pipette aspiration affords the pre-cision to isolate single cells from a densely packed matrix of in-
termingling D1R+ and D2R+ MSNs (Figure 3B). Comparison of
averaged single-cell neurexin expression levels between NAc
D1R+ and D2R+ MSNs revealed significant cell-type-specific
differences for Nrxn1a and Nrxn3b (Figures 3C and 3D). In
contrast to the large splice-site diversity of hippocampal inter-
neuron cell types, MSN cell types were similar, with the excep-
tion of Nrxn1 splice site 4 (ss4) probes. Furthermore, expression
of neurexin ligands and Ptpr and Slitrk molecules was similar be-
tween MSN cell types (Figures 3E and 3F), precluding accurate
clustering by all transcriptional profiles except neurexins (Figures
3G–3J). Taken together, these data indicate that cell-type-spe-
cific components of two distinct neural circuits display unique
neurexin transcriptional repertoires.
Distinct Neurexin Splicing in Neurons Projecting to the
Same Target
An alternative definition of cell type within neuronal circuits is the
axonal target region (Kepecs and Fishell, 2014). Long-range pro-
jection neurons often have to navigate complex trajectories to
reach specific areas where they eventually form synapses, and
it is likely that they use extensivemolecular instructions to achieve
this (Zipursky and Sanes, 2010). To seewhether specific patterns
of neurexin expression could be supporting long-range target
specificity, we identified individual projection neurons with a
defined target destination by retrograde viral labeling techniques.
First,we addressed convergent projections that target a common
post-synaptic area by using RV-mediated retrograde tracing
ofNAc inputs from thePFCandmidline thalamic nuclei, twomajor
projection inputs to the NAc (Groenewegen and Berendse, 1994;
Groenewegenet al., 1997). Retrogradeuptakeof amutatedRV, in
which the rabies glycoprotein was replaced by an enhanced yel-
low fluorescent protein (EYFP) cassette (RV(DG)-EYFP), labeled
PFC and thalamic neurons with restricted vGlut1 and Slitrk6
expression, respectively (Figures 4A and 4B). Single-cell profiling
demonstrated that, despite their common synaptic target area,
Nrxn3 transcriptional regulation was unique to each projection
population (Figure 4D).While overall levels of Nrxn1awere similar
in both populations, splice site 2 (ss2) and ss4 inclusion appeared
to be regulated in a projection-specificmanner (Figure 4C). Over-
all, strong clustering of both populations was observed for multi-
ple probe sets (Figures 4G–4J). These data suggest that neurexin
transcriptional profiles are not similar for neuronal populations
with common projection targets.
To extend these findings and explore their generalizability,
we profiled a functionally distinct neural circuit with an overall
architecture similar to that of the NAc. We chose the dorsolateral
striatum (DLS), as it is similarly composed of dopamine receptor-
expressing MSNs that receive long-distance excitatory input
from cortical regions and thalamic nuclei. Retrograde labeling
via an RV expressing tdTomato (RV(DG)-tdTom) strongly labeled
motor cortex and midline thalamus (Figure 5D). Isolated single
neurons exhibited strikingly similar patterns of expression for
regional markers that previously differentiated thalamic and cor-
tical cells projecting to the NAc (compare Figures S3B and S3F).
To simplify our comparison across experiments, we distilled
neurexin expression profiles to the major transcriptional iso-
forms of Nrxn1 and Nrxn3, as well as splice site 3 (ss3), which
previously demonstrated quantitative input-specific differences.
While the overall transcriptional regulation of neurexins demon-
strated similar input-specific patterns (compare Figures 5B and
5C with Figures 5E and 5F), differences were observed in ss3
regulation, particularly for Nrxn1 (Figures 5B and 5E, right
panels). Taken together with the NAc data, it seems that cortical
and thalamic domains have mRNA profiles that supersede spe-
cific circuit connectivity and that Nrxn1 and Nrxn3 transcriptional
variants are part of this identity. However, specific splice iso-
forms of neurexins can be imposed on top of this regional
code to create circuit-specific adhesion diversity.Another possibility is that cortical and thalamic afferents
display substantial bias in their connectivity within the striatum
and that differences in neurexin profiles simply reflect cell-
type-specific projections. To directly address this possibility,
we used a pseudotyped-RV system previously used to transy-
naptically trace inputs to genetically defined cell types (Wicker-
sham et al., 2007; Wall et al., 2013). Stereotaxic injection into
D1R-Cre mice of an adeno-associated virus (AAV) expressing
a Cre-recombinase-sensitive TVA receptor allowed for D1R+
MSN-specific uptake of EnvA-pseudotyped RV and subsequent
retrograde synaptic transport (Figure 5G). Both medial PFC
(mPFC) and midline thalamus were synaptically connected to
NAc D1R+ MSNs (data not shown), and these neurons exhibited
similar marker profiles to their region-specific counterparts
(compare Figures S3B and S3J). Despite restricting our analysis
to a single postsynaptic cell type, we continued to observe a
highly divergent pattern of neurexin transcriptional regulation
(compare Figures 5B and 5C with Figures 5H and 5I), strongly
implying that postsynaptic targeting is not encoded by neurexin
adhesion molecules.
To complement the aforementioned analysis, we explored
divergent projections from a common origin. Specifically, we
chose to examine neighboring PFC neurons with distinct syn-
aptic target regions by simultaneously injecting the NAc with
RV(DG)-EYFP and the lateral hypothalamus (l. Hyp) with
RV(DG)-tdTOM (Figure 6A). Double RV injections labeled two
adjacent populations of PFC cells with no discernable overlap
(Figure 6A). In this set of experiments, neurexin transcriptional
repertoires were identical between these two populations of
divergently projecting neurons, although other transcriptional
differences were readily observed (compare Figures 6C and
6D with Figures 6B and 6E; also, compare Figures 6G and 6I
with Figure 6H). Taken together, the aforementioned approaches
suggest that neurexin transcriptional profiles show character-
istic, reproducible cell-type-specific differences across multiple
brain regions and are not coordinated across connected circuit
constituents (Figures S4B–S4E). Predictive sorting analysis
(see Supplemental Experimental Procedures) further supported
this conclusion, as neurexin transcriptional profiles were of
high predictive value in distinguishing hippocampal interneurons
and ventral striatal cell types (Figure S4F). They predicted these
cell types much more effectively than other synaptic adhesion
molecules or general neuronal transcripts, although somewhat
less effectively than markers previously identified to have cell-
type bias.
Single-Cell Regulation of the Neurexin Family
Numerous molecules are hypothesized to function cell autono-
mously to shape the splicing patterns of neurexins (Resnick
et al., 2008; Rozic et al., 2011, 2013; Iijima et al., 2011, 2014).
It is currently unclear, however, whether such splicing machinery
directs individual neurons toward exclusive expression of single
splice isoforms. To address this question, we analyzed the status
of ss4 within Nrxn1 transcripts across multiple brain regions, as
this locus has a single splice-site insertion (Figure 7A). Notably,
we found that individual neurons were, indeed, capable of ex-
pressing both ss-IN and ss-OUT versions of ss4, although this
configuration was highly dependent on the region analyzedNeuron 87, 326–340, July 15, 2015 ª2015 Elsevier Inc. 331
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Figure 4. Two NAc-Targeting Neuronal Populations Do Not Share Neurexin Expression Patterns
(A) Top: strategy for single-cell isolation of NAc inputs by injection of RV(DG)-EYFP into the NAc core. Bottom: retrograde synaptic uptake of RV by neurons in the
PFC (boxed, left picture) and midline thalamic nuclei (boxed, right picture) following injection into the NAc core (circle, left picture). Thal, thalamus.
(B) Left: heatmap representation of normalized expression of Thal/ NAc and PFC/ NAc for genes known to mark these subtypes. Right: averaged single-cell
expression for Thal/ NAc (n = 28) and PFC/ NAc (n = 23), normalized to Thal/ NAc values.
(C and D) Left: Nrxn a/b isoform expression, normalized to the average level in Thal/ NAc cells. Right: splice-site graph showing averaged single-cell splice
isoform expression values for ss-IN (upward bars) and ss-OUT (downward bars).
(E and F) Averaged single-cell normalized expression values for neurexin ligands (E) and the Ptp/Slitrk family (F).
(G–J) Pearson coefficient correlation plots demonstrating the similarity of individual neurons to the two cell classes being compared for neurexins (G), neurexin
ligands (H), the Ptp/Slitrk family (I), and general neuronal transcripts (J). Cells are color coded according to Thal/ NAc and Thal/ NAc identity. KS values are
given for comparison of single-cell groups.
Data are means ± SEM. Asterisk indicates significant difference between groups (Mann-Whitney U test).
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Figure 5. Comparison of Neurexin Expression Profiles across Diverse Striatal Circuits
(A–C) Data for NAc RV injection have been reproduced from Figure 4 for comparison purposes. Thal, thalamus.
(D) Top: strategy for single-cell isolation of DLS inputs by injection of RV(DG)-tdTOM into the DLS. Bottom: retrograde synaptic uptake of RV by neurons in M1
(boxed, left picture) and midline thalamic nuclei (boxed, right picture) following injection into DLS (circle, left picture).
(E and F) Thalamus-normalized expression of Nrxn1a/b (E, left) and Nrxn3a/b (F, left) in thalamo- (n = 28) and cortico (n = 24)-striatal projection neurons and
normalized expression of Nrx1a, ss3 (E, right) and Nrxn3 a, ss3 (F, right).
(G) Top: strategy for single-cell isolation of NAc D1R+ MSN synaptic inputs by sequential injection procedure.
(H and I) Thalamus-normalized expression of Nrxn1a/b (H, left) and Nrxn3a/b (I, left) in thalamo- (n = 11) and cortico (n = 15)-accumbal projection neurons and
normalized expression of Nrx1a, ss3 (H, right) and Nrxn3 a, ss3 (I, right).
Data are means ± SEM. Asterisk indicates significant difference between groups (Mann-Whitney U test).(Figures 7B–7E). Cortical projection neurons largely excluded
ss4 inserts, regardless of their target region (Figures 7D and
7E), whereas thalamic neurons projecting to the NAc and
D1R+ MSNs found within this structure exhibited either ss4-IN,
ss4-OUT, or coexpression of both species (Figures 7C and
7D). We also performed an alternative analysis to determine
whether there was splice-site correlation across neurexin iso-
forms (i.e., between Nrxn1 and Nrxn3; Figure S5A). Again, we
found that cortical projection neuronswere nearly uniform in their
transcriptional repertoire, with a robust exclusion of ss4 in both
Nrxn1 and Nrxn3 (Figures S5D and S5E), while both CCK+ inter-
neurons and thalamic projection neurons displayed coordinatedss4 exclusion as well as Nrxn1ss4-OUT/Nrxn3ss4-IN combina-
tions (Figures S5B, S5D, and S5E).
Neurexin Transcriptional Signatures Are Altered in
Response to Drug Exposure
Thus far, neurexin transcriptional profiles have been viewed as
static characteristics with cell-type- and circuit-specific expres-
sion. Previous work suggests that activity-dependent processes
can both alter the transcriptional diversity of neurexins (Rozic-
Kotliroff and Zisapel, 2007; Resnick et al., 2008; Iijima et al.,
2011; Rozic et al., 2011, 2013) and shape their function at devel-
oping synapses (Chubykin et al., 2007). To explore the potentialNeuron 87, 326–340, July 15, 2015 ª2015 Elsevier Inc. 333
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Figure 6. Neurexins Do Not Display Target-Region Specificity in Two Prefrontal Circuits
(A) Top: strategy for single-cell isolation of PFC neurons that project to NAc and hypothalamus (Hyp) by coinjection of RV(DG)-EYFP into the NAc core and
RV(DG)-tdTOM into the hypothalamus. Bottom: retrograde synaptic uptake of RVs injected into NAc (left, circle) and hypothalamus (right, circle) by neurons in
adjacent portions of the PFC (left, boxed region).
(B) Left: heatmap representation of normalized expression of PFC/ NAc and PFC/ Hyp for genes significantly different between these populations. Right:
averaged single-cell expression for PFC/ NAc (n = 19) and PFC/ Hyp (n = 10), normalized to PFC/ NAc values for each probe.
(C and D) Left: Nrxn a/b isoform expression, normalized by probe to the average level in PFC/ NAc cells. Right: splice-site graph showing averaged single-cell
splice isoform expression values for ss-IN (upward bars) and ss-OUT (downward bars).
(E and F) Averaged single-cell expression values for neurexin ligands (E) and the Ptp/Slitrk family (F), normalized to PFC/ NAc values for each probe.
(G–J) Pearson coefficient correlation plots demonstrating the similarity of individual neurons to the two cell classes being compared for neurexins (G), neurexin
ligands (H), the Ptp/Slitrk family (I), and general neuronal transcripts (J). Cells are color coded according to PFC/ NAc and PFC/ Hyp identity. KS values are
given for comparison of single-cell groups.
Data are means ± SEM. Asterisk indicates significant difference between groups (Mann-Whitney U test).
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Figure 7. Single-Cell Regulation of Nrxn1 ss4 Selection Is Depen-
dent on Brain Region
(A) Description of Nrxn1 ss4 index, which assesses the exclusive presence of
single-splice isoforms or coexpression of Nrxn1 ss4-IN and Nrxn1 ss4-OUT
transcripts. An index = 0 represents roughly equal normalized expression
values for both Nrx1 ss4-IN and Nrxn1 ss4-OUT probes.
(B–E) Plot of ss4 index for all single neurons collected in hippocampal
interneuron (B, n = 45 cells), NAc MSN (C, n = 33 cells), NAc-projecting
(D, n = 51 cells), and divergent PFC projection (E, n = 29 cells) experiments.
Each plot shows the heatmaps of both Nrx1 ss4 probes for each cell, with
the ss4 index plotted below. Splice-site territories were arbitrarily
subdivided into ss4-IN (index = 0.33–1.00), ss4-IN and ss4-OUT
(index = 0.33–0.33), and ss4-OUT (index = 1.0 to 0.33), and normalized
(Norm.) frequencies were calculated for each region (right histograms).
Thal, midline thalamic nuclei; Hyp, hypothalamus.for plasticity of neurexin transcriptional repertoires, we exposed
animals to chronic non-contingent cocaine administration, an
experience known to cause major synaptic alterations within
NAc circuitry (Bowers et al., 2010; Grueter et al., 2012). Miceexposed to 5 consecutive days of cocaine developed robust
behavioral sensitization, which was manifest by a dramatic in-
crease in locomotor activity, as compared to saline-injected
controls (Figures 8A and 8B). D1R+ MSNs extracted 3 hr after
the last cocaine treatment displayed modest transcriptional
changes, including an increase in the Gria4 subunit of AMPA re-
ceptors (AMPARs) and a decrease in Lrrtm4 (Figures 8C and 8F).
Despite this, no change in the neurexin transcription or splice
code was observed (Figures 8D and 8E) in these cells. In
contrast, D2R+ MSNs from cocaine-injected mice displayed
both modest changes in AMPAR transcripts, as well as large
(>50%) reductions in total Nrxn1 transcriptional activity (Figures
8G and 8H). In addition, these changes were accompanied by
differential expression of specific isoforms of both Nrxn1 and
Nrxn3 (Figures 8H and 8I). Together, these data uncover a cell-
type-specific remodeling of neurexin codes at the single-cell
level following chronic exposure to a drug of abuse.
DISCUSSION
Understanding the molecular machinery that defines circuit and
synapse specificity is a daunting challenge with enormous clin-
ical and therapeutic implications. Synaptic adhesion molecules
in general, and neurexins in particular, have been proposed to
contribute to circuit formation within the nervous system (Aoto
et al., 2013; Futai et al., 2013; Ullrich et al., 1995; Ushkaryov
et al., 1992). Here, we used single-cell qRT-PCR to illuminate
the expression profiles and differential splicing of neurexin
mRNAs from individual neurons embedded in mature neural cir-
cuits. These experiments are the first to address at the single-
neuron level the existence of a ‘‘synaptic adhesion code’’—a
regulated, combinatorial expression of synaptic adhesion mole-
cules that could contain molecular instructions for the hierarchi-
cal organization of synapses, including the connectivity of spe-
cific neuronal populations, the precise sub-cellular localization
of synaptic contacts, the specific strength andmolecular compo-
sition of these connections, and their ability to bemodified by the
environment (see Figure S6). By combining genetic and viral cir-
cuit mapping techniques, microfluidics technology, and a novel
qPCR probe design, we assessed the contributions of neurexin
transcriptional diversity to such codes. First, we found that sin-
gle-neuron analysis of hippocampal CA1 transcriptional profiles
had several advantages over tissue mRNA sampling, including
lower detection levels of genes commonly associated with glial
populations, unparalleled access to sparse neuronal popula-
tions, and invaluable estimates of the variance of transcript
expression within neuronal populations. Second, by using this
technique, we reached several conclusions regarding neurexins
that could not have been demonstrated otherwise. (1) Neurexins
exhibit cell-type-specific expression patterns that are reproduc-
ible across neurons; (2) neuronswith common long-rangeprojec-
tion targets or cell-type-specific connectivity do not necessarily
use similar neurexin transcriptional codes; (3) coordination of
neurexin alternative splicing is specific to brain regions; and (4)
neurexin expression profiles can be altered in a cell-type-specific
manner in response to chronic cocaine treatment.
Recent deep-sequencing technologies have provided in-
depth and comprehensive cataloging of potential neurexinNeuron 87, 326–340, July 15, 2015 ª2015 Elsevier Inc. 335
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(B) Behavioral sensitization was manifest by steady increase in locomotor activity in the cocaine group as compared with saline controls over sequential days of
cocaine administration.
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(legend continued on next page)
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transcriptional repertoires fromwhole-brain, PFC, and cerebellar
granule cell cultures (Treutlein et al., 2014; Schreiner et al., 2014).
While these molecule-centered sequencing approaches nearly
mapped the full extent of neurexin diversity, technical limitations
required large sample input, making it impossible to assess
whether individual neurons regulate neurexin diversity to encode
synaptic connectivity within neural circuits. Our data directly
address this problem by demonstrating reproducible cell-type-
and circuit-specific expression of different families of Nrxns as
well as other synaptic adhesion molecules. Exploration of the
neurexin transcriptional repertoire of hippocampal GABAergic
interneurons and striatal MSNs suggested that neurexin expres-
sion is tightly and reproducibly regulated at the single-cell level.
How this transcriptional diversity is achieved depends on the
brain region: MSNs may exclusively utilize promoter selection
to control transcriptional output, while basket cell populations
additionally use post-transcriptional splicing to enhance differ-
ences in their neurexin profiles. Further work will be needed to
determine whether the enhanced neurexin transcriptional diver-
gence of interneurons, as compared to MSNs, is related to the
unique developmental origins of the PV+ and CCK+ cells, their
different activity levels, or their particular splicing machinery
(Rozic-Kotliroff and Zisapel, 2007; Resnick et al., 2008; Tricoire
et al., 2011; Ehrmann et al., 2013; Iijima et al., 2014; See et al.,
2014), as well as whether these differences have a functional
role in specifying the distinct synaptic properties of these diverse
subclasses.
A series of experiments performed to probe the correlation be-
tween synaptic target area and neurexin expression profile sug-
gest that neurexins alone do not encode target specificity.
Cortical and thalamic afferent projection neuronswere examined
for functionally and anatomically distinct striatal circuits and re-
vealed highly divergent input-specific neurexin profiles. How-
ever, although individual cortical or thalamic populations of
neurons participate in non-overlapping cortico-striato-thalamic
circuits, comparisons between these populations of neurons
demonstrated conserved regulation of neurexin transcription,
with differences restricted to splice-site utilization. These results
raise the intriguing possibility that splice-site control provides an
alternative evolutionary mechanism for diversification of neu-
rexin expression patterns from regionally conserved templates.
Further analysis of a cortico-striato-thalamic circuit synaptically
connected to D1R+ MSNs demonstrated that input-specific
neurexin profiles are also not a result of biased-cell-type connec-
tivity. In contrast to these data, PFC neurons projecting to the
hypothalamus and NAc inhabited distinct cortical layers but
still exhibited identical neurexin expression patterns. Together,
these data make a strong argument that target region is not en-
coded by neurexin diversity, consistent with previous reports
that a-neurexin knockout mice do not display deficits in axonal
projections of olfactory circuits (Dudanova et al., 2007). Further-
more, we demonstrate that neurexin profiles do not encode
cell-type-specific connectivity, suggesting that it is unlikely thatshowing averaged single-cell splice isoform expression values for ss-IN (upward
D1R+ (E) and D2R+ (I) MSN subtype. (F and J) Averaged single-cell expression of
(J) subtype, with expression values normalized to the saline controls for each pr
Data are means ± SEM. Asterisk indicates significant difference between groupsneurexins function as a map on which patterns of neuronal con-
nectivity are established.
Our analyses exploring single-cell relationships between
individual neurexin splice isoforms could have substantial im-
plications for understanding the genetics of neuropsychiatric
illness, as this gene family is extensively linked to human neu-
ropsychiatric disease (Elia et al., 2010; Pinto et al., 2010; Tam
et al., 2009). Understanding how mutations in neurexins even-
tually lead to behavioral abnormalities requires the discovery
of ‘‘molecularly vulnerable circuits,’’ specific neuronal popula-
tions that cannot functionally compensate for gene mutations
because they lack genetic redundancy or are inherently vulner-
able to small changes in synapse properties (Rothwell et al.,
2014; Soler-Llavina et al., 2011). Coordinated cellular splicing
of Nrxns could be an important source of such molecular re-
dundancy, as evidenced by the interchangeability of neurexin
isoforms lacking ss4 for the maintenance of AMPAR function
(Aoto et al., 2013). Following this logic, cortical projection neu-
rons—which exclusively coordinate, via alternative splicing,
Nrxn1 and Nrxn3 ss4 exclusion—are unlikely to be as vulnerable
to single-gene loss as NAc-projecting thalamic neurons, which
could not use Nrxn3 expression to replace Nrxn1 deficiencies
because of conflicting splice-site usage. Unfortunately, tran-
scriptional patterns read out at the soma provide little informa-
tion about the targeting of mRNA populations to specific den-
dritic or axonal compartments. If synaptic adhesion molecules
are recruited in a synapse-specific manner, mutations may
uniquely perturb select sets of inputs. Nonetheless, single-
neuron transcriptional analyses of this sort clearly provide a
powerful new tool for the prediction of molecularly vulnerable
disease-relevant circuits in the future.
If neurexins do encode cell-type-specific information about
synaptic function, understanding their potential for plasticity
could provide essential mechanistic information about how
neural circuits modify themselves in response to environmental
experience. To explore this, we chronically administered cocaine
to mice and detailed how their synaptic adhesion profiles
changed during behavioral sensitization. Surprisingly, 5 days
of cocaine administration demonstrated remarkably subtle
effects on the overall transcriptional profiles of NAcMSNs, which
are known to undergo significant synaptic remodeling 2 weeks
following cocaine exposure (Huang et al., 2009; Kim et al.,
2011; Russo et al., 2010). However, we observed an 50%
downregulation of Nrxn1a transcripts exclusively in D2R+
MSNs, along with decreases in the abundance of ss2-OUT and
ss3-IN isoforms. Previous work has demonstrated activity-
dependent changes in neurexin alternative splicing (Patzke and
Ernsberger, 2000; Rozic-Kotliroff and Zisapel, 2007; Rozic
et al., 2013; Iijima et al., 2014). Previous reports, together with
our data, make it clear that the pattern of neurexin splicing in
the nervous system is sensitive to a range of physiological stim-
uli. While more work is required to understand the significance of
both baseline adhesion profiles and behaviorally inducedbars) and ss-OUT (downward bars) for saline- versus cocaine-treated mice of
neurexin ligands for saline- versus cocaine-treated mice of D1R+ (F) and D2R+
obe.
(Mann-Whitney U test).
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alterations, we believe that our single-cell analysis of synaptic
adhesion molecule transcription provides a broad foundation
for understanding how molecules encode synaptic function
and how this is altered by the environment and disease.
EXPERIMENTAL PROCEDURES
Animals
All procedures conformed to the NIH Guidelines for the Care and Use of Lab-
oratory Animals and were approved by the Stanford University Administrative
Panel on Laboratory Animal Care.
Single-Cell Transcriptional Profiling
Acute brain slices were cut, and patch pipettes were used for cytosol ex-
traction. Samples then underwent reverse transcription and target-specific
amplification, followed by qPCR. Further details are found in Supplemental
Experimental Procedures.
Primetime Assay Design
All Primetime assays were ordered from Integrated DNA Technologies (IDT).
Assays were designed to generate amplicons of 70–100 bp in length that
bridged exon-intron junctions. Wherever possible, ss-IN- and ss-OUT-specific
assays differed by only a single primer. The complexity of neurexin splicing is
such that ss-IN can include many similar exons differentiated by only a few
amino acids. In these instances, effort was taken to design primers that would
recognize the largest number of potential ss-IN products. Probes passing ef-
ficiency criteria (>90%) as described by
Amplication Efficiency = 10ð1=slopeÞ  1
were subjected to qPCR with plasmid templates of known neurexin
splicing combinations to test for probe specificity. The final probe set
included 170 probes, 146 of which were unique (see Table S1 for
sequences).
Data Analysis
All Ct data were calculated by Biomark acquisition software, exported as .csv
files, and analyzed in Mathematica version 9.0 (Wolfram Research) with
custom written protocols. Each chip run included eight tissue cDNA dilutions
to monitor the efficiencies of probes across experiments. Ct values were con-
verted to normalized expression levels by the following formula:
Norm: ExpressionProbeA = 2Ct
probeACtnorm: probes ;
where Ct norm. probes is the average Ct of two Actb probes and Atp1b1. With
these normalizer probes, nearly all expression values fell between 0 and 1.
Single cells, whose normalizer value was ±2 cycles from overall normalizer
average, were omitted from further analysis. In nucleus accumbens exper-
iments, Lhx8+ cells were removed from the dataset, as they likely repre-
sented cholinergic interneurons (Zhao et al., 2003); all other cells were
analyzed. Heatmaps were generated with the ArrayPlot function in Mathe-
matica and scaled to the highest and lowest global normalized expression
values in a given dataset. For data sorting, cell type was always defined by
transgenic mouse line or viral labeling. Expression values were compared
between two defined cell populations using Mann-Whitney U test, with sig-
nificance set at p < 0.05. Tissue versus single-cell comparisons were
analyzed using two-way ANOVA followed by Tukey’s multiple comparison
post hoc tests. All summary expression data are displayed as mean ±
SEM. With the exception of splice-site-specific probes, expression was
normalized to the first cell type in each respective figure (B–F in Figures
2, 3, 4, and 6). All comparisons were made between cell types for each
probe to avoid confounding cross-probe differences in sensitivity.
Clustering
Clustering was used to group cells by similarity of transcriptional profile. For
each chip, probes were rank-ordered by overall population variance, and the
top 50% of high-variance probes were used for clustering. Probe groups338 Neuron 87, 326–340, July 15, 2015 ª2015 Elsevier Inc.included: Neurexins (Nrxn1a, Nrxn1b, Nrxn3a, Nrx3b, and all Nrxn1 and
Nrxn3 splice sites); neurexin ligands (Nlgn1–3, Lrrtm1–4, Lphn1–3, Crbln1,
Crbln2, and Crbln4); Ptp/Slitrk (Ptprs, Ptprd, Ptprf, and Slitrk1–6); and neuronal
(NeuN, Nefl, Mapt, Gad65, Syt1, Vamp3, Grm1, and Grm5). Pearson’s corre-
lation coefficient (‘‘Correlation’’ function in Mathematica) was calculated be-
tween all cells, and single-cell matriceswere created describing the correlation
of each cell to the two experimental populations. Cluster plots were assayed
for significance using the Kolmogarov-Smirnov test.
Predictive Sorting
Predictive sorting was used to test the efficacy of transcriptional profiles in dis-
tinguishing cell-type identity. In brief, single-cell data were analyzed by the
‘‘ClusteringComponents’’ function in Mathematica (Euclidean distance func-
tion for 500 sequential iterations) to create two cell populations (group A and
group B). The following formula was used to create a weighted predictive sort-
ing measure:
Accuracy =
 
NcorrectA
NtotalA
!
NtotalA
N

+
 
NcorrectB
NtotalB
!
NtotalB
N

;
where N = the total number of single cells, NA = cells in group A, and NB = cells
in group B.
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